Page last updated: 2024-10-29

indomethacin and Brain Disorders

indomethacin has been researched along with Brain Disorders in 18 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research Excerpts

ExcerptRelevanceReference
"Cerebral hematoma enhances vasoconstriction induced by topical application of the vasoconstrictor agents endothelin-1 (ET-1) and leukotriene C4 (LTC4)."7.69Hematoma-induced enhanced cerebral vasoconstrictions to leukotriene C4 and endothelin-1 in piglets: role of prostanoids. ( Leffler, CW; Shibata, M; Yakubu, MA, 1995)
"Cerebral hematoma enhances vasoconstriction induced by topical application of the vasoconstrictor agents endothelin-1 (ET-1) and leukotriene C4 (LTC4)."3.69Hematoma-induced enhanced cerebral vasoconstrictions to leukotriene C4 and endothelin-1 in piglets: role of prostanoids. ( Leffler, CW; Shibata, M; Yakubu, MA, 1995)
"The diagnosis of hemicrania continua was made according to the International Headache Society (IHS) criteria."1.34Hemicrania continua secondary to an ipsilateral brainstem lesion. ( Andrade-Valença, LP; da Silva, WF; Dodick, DW; Valença, MM, 2007)
"Indomethacin has been most effective but not free of significant complications."1.26Premature onset of labor, neonatal patent ductus arteriosus, and prostaglandin synthetase antagonists--a rat model of a human problem. ( Altmiller, DH; Altshuler, G; Krous, HF; Sharpe, GL, 1979)

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19907 (38.89)18.7374
1990's6 (33.33)18.2507
2000's5 (27.78)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golombek, SG1
Sola, A1
Baquero, H1
Borbonet, D1
Cabañas, F1
Fajardo, C1
Goldsmit, G1
Lemus, L1
Miura, E1
Pellicer, A1
Pérez, JM1
Rogido, M1
Zambosco, G1
van Overmeire, B1
Schmidt, B1
Asztalos, EV1
Roberts, RS1
Robertson, CM1
Sauve, RS1
Whitfield, MF1
Rushing, S1
Ment, LR2
Levene, M1
Valença, MM1
Andrade-Valença, LP1
da Silva, WF1
Dodick, DW1
Ducobu, J1
Dupont, P1
Baethmann, A1
Maier-Hauff, K1
Kempski, O1
Unterberg, A1
Wahl, M1
Siesjö, BK1
Rehncrona, S1
Smith, D1
Yakubu, MA1
Shibata, M1
Leffler, CW1
Mendonca, EV1
Stone, RC1
Rosa, FC1
Yirmiya, R1
Barak, O1
Avitsur, R1
Gallily, R1
Weidenfeld, J1
Vohr, B1
Allan, WC1
Scott, DT1
Katz, KH1
Schneider, KC1
Makuch, RW1
Altshuler, G1
Krous, HF1
Altmiller, DH1
Sharpe, GL1
Lagrue, G1
Leroux-Robert, C1
Nebout, T1
Mentz, P1
Giessler, C1
Chan, GL1
Weinstein, SS1
Wright, CE1
Bowers, VD1
Alveranga, DY1
Shires, DL1
Ackermann, JR1
LeFor, WW1
Kahana, L1
Seidel, G1
Back, G1
Payk, TR1
Vliegen, J1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Best Treatment Strategy: Surgical Versus Pharmacological, to Close the Ductus Arteriosus Persistent in Preterm Infants. A Randomized Controlled Trial[NCT02602054]Phase 240 participants (Anticipated)Interventional2015-10-31Recruiting
Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)[NCT00009646]Phase 31,202 participants (Actual)Interventional1993-11-30Completed
Lactoferrin Infant Feeding Trial - LIFT_Canada[NCT03367013]Phase 3453 participants (Actual)Interventional2018-02-16Active, not recruiting
Enteral Supplementation With High-dose Docosahexaenoic Acid on the Risk for Bronchopulmonary Dysplasia in Very Preterm Infants: A Collaborative Study Protocol for an Individual Participant Data Meta-analysis[NCT05915806]1,801 participants (Actual)Interventional2023-07-30Active, not recruiting
Clinical Research on the Predictive Effect of Neonatal Morbidities on the Poor Outcomes to Very Low Birth-weight and Extremely Low Birth-weight Infants[NCT03104946]834 participants (Actual)Observational2013-09-01Completed
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage[NCT00665769]103 participants (Actual)Interventional2008-06-30Terminated (stopped due to Recruitment was proceeding too slowly)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for indomethacin and Brain Disorders

ArticleYear
Minimising neonatal brain injury: how research in the past five years has changed my clinical practice.
    Archives of disease in childhood, 2007, Volume: 92, Issue:3

    Topics: Animals; Birth Injuries; Brain Diseases; Dexamethasone; Disease Models, Animal; Ethamsylate; Humans;

2007
[Nephrology in 1979].
    La Revue du praticien, 1979, Apr-21, Volume: 29, Issue:23

    Topics: Bartter Syndrome; Brain Diseases; Humans; Hyperaldosteronism; Hypertension; Indomethacin; Kidney Fai

1979

Trials

2 trials available for indomethacin and Brain Disorders

ArticleYear
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    JAMA, 2003, Mar-05, Volume: 289, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blindness; Brain Diseases; Bronchopulmonary Dysplasia; Cere

2003
Early-onset intraventricular hemorrhage in preterm neonates: incidence of neurodevelopmental handicap.
    Seminars in perinatology, 1999, Volume: 23, Issue:3

    Topics: Aging; Brain Diseases; Cerebral Hemorrhage; Cerebral Palsy; Humans; Indomethacin; Infant, Newborn; I

1999

Other Studies

14 other studies available for indomethacin and Brain Disorders

ArticleYear
[First SIBEN clinical consensus: diagnostic and therapeutic approach to patent ductus arteriosus in premature newborns].
    Anales de pediatria (Barcelona, Spain : 2003), 2008, Volume: 69, Issue:5

    Topics: Age Factors; Brain Diseases; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Diuretics; Ductus Art

2008
Preterm birth: a cost benefit analysis.
    Seminars in perinatology, 2004, Volume: 28, Issue:6

    Topics: Adrenal Cortex Hormones; Age Factors; Brain Diseases; Cardiovascular Agents; Cost-Benefit Analysis;

2004
Hemicrania continua secondary to an ipsilateral brainstem lesion.
    Headache, 2007, Volume: 47, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Brain Diseases; Brain Stem; Female; Headache; Humans; Indom

2007
[Inhibition of prostaglandins in the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)].
    Presse medicale (Paris, France : 1983), 1983, May-07, Volume: 12, Issue:20

    Topics: Adult; Aged; Aspirin; Brain Diseases; Ethanol; Female; Humans; Inappropriate ADH Syndrome; Indometha

1983
Therapeutic considerations in blood-brain barrier disturbances.
    Acta neuropathologica. Supplementum, 1983, Volume: 8

    Topics: Animals; Barbiturates; Blood-Brain Barrier; Brain Diseases; Brain Edema; Brain Injuries; Humans; Ind

1983
Neuronal cell damage in the brain: possible involvement of oxidative mechanisms.
    Acta physiologica Scandinavica. Supplementum, 1980, Volume: 492

    Topics: Animals; Brain Diseases; Brain Ischemia; Cerebrovascular Circulation; Hypoglycemia; Hypoxia; Indomet

1980
Hematoma-induced enhanced cerebral vasoconstrictions to leukotriene C4 and endothelin-1 in piglets: role of prostanoids.
    Pediatric research, 1995, Volume: 38, Issue:1

    Topics: Animals; Animals, Newborn; Brain Diseases; Cerebral Arteries; Endothelins; Hematoma; Indomethacin; L

1995
Prevention of intracranial calcifications and brain damage associated with nephrogenic diabetes insipidus.
    Pediatric nephrology (Berlin, Germany), 1994, Volume: 8, Issue:2

    Topics: Adolescent; Brain Diseases; Calcinosis; Child; Diabetes Insipidus; Humans; Hydrochlorothiazide; Hype

1994
Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins.
    Brain research, 1997, Feb-21, Volume: 749, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Body Temperature; Body Weight; B

1997
Premature onset of labor, neonatal patent ductus arteriosus, and prostaglandin synthetase antagonists--a rat model of a human problem.
    American journal of obstetrics and gynecology, 1979, Sep-15, Volume: 135, Issue:2

    Topics: Animals; Brain Diseases; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ductus Arterio

1979
Biosynthesis of TXB2 and 6-oxo-PGF1 alpha in the heart and other tissues under pathophysiological conditions.
    Agents and actions. Supplements, 1992, Volume: 37

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aqueous Humor; Brain Diseases; Child; Gastric Mucosa; Gastrit

1992
Encephalopathy associated with OKT3 administration. Possible interaction with indomethacin.
    Transplantation, 1991, Volume: 52, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Brain Diseases; Drug Interactions; Female; Humans; Indomethacin; Kidn

1991
Proceedings: Therapy of the lymphostatic encephalopathy in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 1974, Volume: 282, Issue:Suppl

    Topics: Alkaloids; Animals; Aprotinin; Brain Diseases; Cellulose; Coumarins; Indoles; Indomethacin; Lymphati

1974
[Polyneuritic manifestations in rheumatic diseases].
    Fortschritte der Medizin, 1973, Mar-22, Volume: 91, Issue:9

    Topics: Adult; Brain Diseases; Facial Paralysis; Female; Humans; Indomethacin; Male; Middle Aged; Penicillin

1973